Rapport Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72M | 2.4M | 29.70 |
| 2025-03-31 | $13M | 1.2M | 10.03 |
| 2024-12-31 | $22M | 1.3M | 17.74 |
| 2024-09-30 | $26M | 1.2M | 20.48 |